MK Mass

A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients

B. Weinstock-Guttman, J. Simon, F. Munschauer, 1995 .